 Analysis interferon-inducible genes cells chronic myeloid leukemia patients interferon-alpha treatment Recombinant human interferon-alpha IFN-alpha hematologic remission patients chronic myeloid leukemia patients resistant others late resistance IFN-alpha treatment molecular mechanism resistance expression IFN-inducible genes cells resistant patients responsive patients healthy controls Northern blot hybridizations genes vitro IFN-alpha peripheral blood cells patients healthy controls genes inducible peripheral blood bone marrow cells resistant patients injection IFN-alpha resistance IFN-alpha treatment chronic myeloid leukemia patients due absence induction IFN-inducible genes low-molecular-weight synthetase presence antagonist IFN-alpha peripheral blood bone marrow cells presence anti-IFN-alpha antibodies